IL270273B1 - Improved extended release highly loaded drug compositions - Google Patents
Improved extended release highly loaded drug compositionsInfo
- Publication number
- IL270273B1 IL270273B1 IL270273A IL27027319A IL270273B1 IL 270273 B1 IL270273 B1 IL 270273B1 IL 270273 A IL270273 A IL 270273A IL 27027319 A IL27027319 A IL 27027319A IL 270273 B1 IL270273 B1 IL 270273B1
- Authority
- IL
- Israel
- Prior art keywords
- extended release
- highly loaded
- drug compositions
- loaded drug
- improved extended
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000013265 extended release Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762500078P | 2017-05-02 | 2017-05-02 | |
PCT/US2018/030380 WO2018204317A1 (en) | 2017-05-02 | 2018-05-01 | Improved extended release highly loaded drug compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
IL270273A IL270273A (en) | 2019-12-31 |
IL270273B1 true IL270273B1 (en) | 2023-03-01 |
IL270273B2 IL270273B2 (en) | 2023-07-01 |
Family
ID=62200552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL270273A IL270273B2 (en) | 2017-05-02 | 2019-10-29 | Improved extended release highly loaded drug compositions |
Country Status (12)
Country | Link |
---|---|
US (2) | US20200113839A1 (en) |
EP (1) | EP3618813B1 (en) |
JP (1) | JP7132947B2 (en) |
KR (1) | KR20190139942A (en) |
CN (1) | CN110709068B (en) |
BR (1) | BR112019022896A2 (en) |
CA (1) | CA3062158A1 (en) |
CO (1) | CO2019013554A2 (en) |
ES (1) | ES2924236T3 (en) |
IL (1) | IL270273B2 (en) |
PE (1) | PE20191795A1 (en) |
WO (1) | WO2018204317A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109839460A (en) * | 2019-03-14 | 2019-06-04 | 上海海虹实业(集团)巢湖今辰药业有限公司 | A kind of detection method of the Amoxicillin in relation to substance |
CN110824066B (en) * | 2019-12-09 | 2022-05-20 | 北京悦康科创医药科技股份有限公司 | Detection method of cefotaxime sodium related substances |
JP7300725B2 (en) * | 2020-02-27 | 2023-06-30 | 日新製薬株式会社 | Solid formulation and its manufacturing method |
CN112986435B (en) * | 2021-02-23 | 2022-08-05 | 海南通用三洋药业有限公司 | Method for determining related substances of ampicillin sodium and sulbactam sodium for injection |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2798053A (en) | 1952-09-03 | 1957-07-02 | Goodrich Co B F | Carboxylic polymers |
GB831897A (en) * | 1957-07-08 | 1960-04-06 | Bristol Myers Co | Antacid preparation and process for making same |
US3915921A (en) | 1974-07-02 | 1975-10-28 | Goodrich Co B F | Unsaturated carboxylic acid-long chain alkyl ester copolymers and tri-polymers water thickening agents and emulsifiers |
US4267103A (en) | 1978-12-07 | 1981-05-12 | The B. F. Goodrich Company | Solvent polymerization of carboxyl containing monomers |
US4664915A (en) * | 1981-07-01 | 1987-05-12 | Bristol-Myers Company | Compressed and formed alkaline component suitable for use in buffered aspirin product |
US5288814A (en) | 1992-08-26 | 1994-02-22 | The B. F. Goodrich Company | Easy to disperse polycarboxylic acid thickeners |
US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
JP4454985B2 (en) * | 2002-08-08 | 2010-04-21 | 第一三共株式会社 | Pharmaceutical composition for lowering blood lipids |
WO2004069234A1 (en) * | 2003-02-05 | 2004-08-19 | Ipca Laboratories Limited | Pharmaceutical compositions and process of production thereof |
ES2702608T3 (en) * | 2004-06-10 | 2019-03-04 | Glatt Air Techniques Inc | Pharmaceutical dosage formulation with controlled release matrix |
FR2879930B1 (en) * | 2004-12-23 | 2007-08-31 | Oralance Pharma Sa | NEW GALENIC SYSTEM FOR TRANSPORTING ASSETS, PROCESS FOR PREPARATION AND USE |
WO2006082523A2 (en) * | 2005-01-25 | 2006-08-10 | Aurobindo Pharma Limited | Pharmaceutical sustained release composition of metformin |
CA2595988A1 (en) * | 2005-01-27 | 2006-08-03 | Alembic Limited | Extended release formulation of levetiracetam |
US20070148238A1 (en) * | 2005-06-23 | 2007-06-28 | Spherics, Inc. | Dosage forms for movement disorder treatment |
BRPI0612594A2 (en) * | 2005-06-29 | 2010-11-23 | Panacea Biotec Ltd | modified release pharmaceutical compositions and process for their preparation |
CA2653011A1 (en) * | 2008-12-03 | 2010-06-03 | Apotex Technologies Inc | Method and apparatus for packaging and dispensing pharmaceuticals |
JP5662453B2 (en) * | 2009-10-02 | 2015-01-28 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Therapeutic use of pharmaceutical compositions |
TWI636783B (en) * | 2012-04-18 | 2018-10-01 | 友霖生技醫藥股份有限公司 | Stable formulations of pitavastatin |
WO2015110962A1 (en) * | 2014-01-21 | 2015-07-30 | Wockhardt Limited | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and linagliptin or salts thereof |
-
2018
- 2018-05-01 JP JP2019560166A patent/JP7132947B2/en active Active
- 2018-05-01 ES ES18725989T patent/ES2924236T3/en active Active
- 2018-05-01 EP EP18725989.0A patent/EP3618813B1/en active Active
- 2018-05-01 CA CA3062158A patent/CA3062158A1/en active Pending
- 2018-05-01 CN CN201880034506.0A patent/CN110709068B/en active Active
- 2018-05-01 US US16/609,912 patent/US20200113839A1/en not_active Abandoned
- 2018-05-01 BR BR112019022896A patent/BR112019022896A2/en active Search and Examination
- 2018-05-01 KR KR1020197033339A patent/KR20190139942A/en not_active Application Discontinuation
- 2018-05-01 PE PE2019002279A patent/PE20191795A1/en unknown
- 2018-05-01 WO PCT/US2018/030380 patent/WO2018204317A1/en active Application Filing
-
2019
- 2019-10-29 IL IL270273A patent/IL270273B2/en unknown
- 2019-11-29 CO CONC2019/0013554A patent/CO2019013554A2/en unknown
-
2021
- 2021-09-29 US US17/489,137 patent/US20220016035A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2018204317A1 (en) | 2018-11-08 |
CN110709068A (en) | 2020-01-17 |
CN110709068B (en) | 2022-11-08 |
ES2924236T3 (en) | 2022-10-05 |
IL270273A (en) | 2019-12-31 |
US20200113839A1 (en) | 2020-04-16 |
PE20191795A1 (en) | 2019-12-24 |
JP2020518614A (en) | 2020-06-25 |
US20220016035A1 (en) | 2022-01-20 |
EP3618813B1 (en) | 2022-07-06 |
EP3618813A1 (en) | 2020-03-11 |
BR112019022896A2 (en) | 2020-05-19 |
CO2019013554A2 (en) | 2020-04-01 |
KR20190139942A (en) | 2019-12-18 |
CA3062158A1 (en) | 2018-11-08 |
IL270273B2 (en) | 2023-07-01 |
JP7132947B2 (en) | 2022-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL271657A (en) | Pharmaceutical compositions | |
IL269061A (en) | Pharmaceutical composition comprising selexipag | |
IL271986A (en) | Pharmaceutical composition | |
IL287520A (en) | Extended release pharmaceutical compositions of levetiracetam | |
IL271759B1 (en) | Pharmaceutical compositions comprising entrectinib | |
GB201608323D0 (en) | Pharmaceutical compositions | |
GB201712159D0 (en) | Pharmaceutical composition | |
IL270273B1 (en) | Improved extended release highly loaded drug compositions | |
GB201705303D0 (en) | Pharmaceutical compositions | |
SG11202001179YA (en) | Pharmaceutical compositions | |
IL272419A (en) | Pharmaceutical composition | |
PT3583943T (en) | Pharmaceutical composition | |
GB201705305D0 (en) | Pharmaceutical compositions | |
IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
GB201719447D0 (en) | Pharmaceutical composition | |
GB201705304D0 (en) | Pharmaceutical compositions | |
GB201705306D0 (en) | Pharmaceutical compositions | |
EP3727485C0 (en) | Pharmaceutical composition | |
IL268146A (en) | Extended release methazolamide formulation | |
GB201611920D0 (en) | Pharmaceutical compositions | |
IL272044A (en) | Pharmaceutical compositions | |
ZA202000014B (en) | Pharmaceutical compositions | |
HUE065294T2 (en) | Delayed sustained release pharmaceutical compositions | |
PT3490535T (en) | Sustained release composition comprising micronized tolcapone | |
HUE057830T2 (en) | Pharmaceutical composition comprising famitinib |